Navigation Links
Transfection Reagent Selector Kit Handbook

only)

The ratios of DNA to Enhancer provided in the selector protocol should not be changed. The ratio of DNA to Enhancer is 1 g of DNA to 8 l of Enhancer. Efficient condensation of DNA with Enhancer is only determined by the mass quantity of DNA. (Cell line or plasmid size do not influence the DNA-to-Enhancer ratio).

Ratio of Transfection Reagent to DNA

The ratio of Transfection Reagent (l) to DNA (g) is an important factor to optimize for every new cell line and DNA construct used. Optimal binding of Transfection ReagentDNA complexes to the negatively charged groups (e.g. sialylated glycoproteins) on the cell surface requires a slightly net positive charge. For Effectene Reagent, the overall charge of the Transfection ReagentDNA complex is determined by the ratio of Transfection Reagent to DNAEnhancer mixture. For SuperFect Reagent, the overall charge of the Transfection ReagentDNA complex is determined by the ratio of Transfection Reagent to DNA. Figure 2 represents a pipetting scheme for optimizing the ratio of DNA to Transfection Reagent for transfection of adherent cells or suspension cells in 6-well plates.

Incubation period with Transfection ReagentDNA complexes
For SuperFect Reagent:


For adherent cells, the length of incubation of transfection complexes with cells should be optimized by varying the incubation time within a range of 116 h. Optimal results are typically obtained by choosing periods of 23 h.

For suspension cells, experiments have shown that in most cases removal of SuperFectDNA transfection complexes is not necessary. However, if cytotoxic
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

Related biology technology :

1. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
2. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
3. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
4. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
5. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
6. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
7. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
8. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
9. Efficient Transfection of Neurospora Crassa
10. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
11. Efficient Transfection of Neurospora Crassa
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Transfection Reagent Selector Kit Handbook

Breaking Biology Technology:Dendreon Appoints Hans Bishop as Chief Operating Officer 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6